Major Shareholder Announcement
COPENHAGEN, Denmark; July 1, 2022 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Wellington Management Group LLP has informed us that, as of June 30, 2022 Wellington Management Group LLP had decreased their holding of shares in Genmab A/S to 4.97% of the share capital and voting rights in Genmab A/S, so that through shares and financial instruments they held the voting rights to a total of 3,278,677 shares in Genmab A/S, which amounts to 4.98% of the share capital and voting rights in Genmab A/S.
Genmab is headquartered in Copenhagen, Denmak with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com and follow us on Twitter.com/Genmab.
Andrew Carlsen, Vice President, Head of Investor Relations
Company Announcement no. 27